CapitalStars Financial Research Pvt Ltd

CapitalStars

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Wednesday, 8 November 2017

Capitalstars Updates:Mkts set to open flat; SGX Nifty up 4 pts: 8 Nov 2017

Capitalstars Updates: Equity Market Outlook

Indian Indices:

Indian benchmark indices are likely to open flat to lower on Wednesday, tracking muted cues from Nifty futures on the Singapore Stock Exchange and soft trend across global peers. Markets across Asia were trading flat as investors weighed disappointing corporate earnings. Ashok Leyland and OBC Q2 stocks to be in focus today. SGX Nifty is trading at 10415 up by 4 points indicating a flat opening.

Indian shares fell sharply on Tuesday and the rupee weakened amid concerns that rising oil prices may lift inflation and hit economic growth. Heavy selling in the Pharma sector on concerns over regulatory hurdles also weighed on markets. The benchmark BSE Sensex tumbled 360.43 points.

Global Market:

• U.S. stocks fell as investors turned their attention to fiscal policy, with tax writers from the House of Representatives expected to hammer out their plan this week
• Asian stocks declined, suggesting a pause in a rally that lifted regional equities to the highest levels in at least a decade
• Key data to watch in the US today are MBA Mortgage Applications

Major Headlines of the day:

• SUN PHARMA-TARO Q2:
o Operating profit at $88.8 mn vs $141.5 mn, down 37% (Beats Street Estimates)
o Operating Margins at 52.2% vs 61.8% (Beats Street Estimates)
o Net sales at $169.9 mn
o Net profit at $52.4 mn

• DHAMPUR SUGAR Q2:
o Revenue up 15 percent at Rs 802 crore
o Net profit up 62 percent at Rs 60 crore
o EBITDA up 14 percent at Rs 121 crore
o Margin at 15.1 percent versus 15.2 percent

• DCM SHRIRAM Q2:
o Revenue up 17.5 percent at Rs 1,605 crore
o Net profit up 88 percent at Rs 172 crore
o EBITDA up 138.5 percent at Rs 291 crore
o Margin at 18.1 percent versus 8.9 percent

• L&T TECHNOLOGY SERVICES Q2:
o Revenue up 9.5 percent at Rs 901 crore
o Net profit up 25.5 percent at Rs 12.3 crore
o EBIT up 10 percent at Rs 138 crore
o Margin at 15.3 percent versus 15.2 percent

• TATA COFFEE Q2:
o Revenue up 4 percent at Rs 382 crore
o Net profit down 23 percent at Rs 23 crore
o EBITDA down 15.5 percent at Rs 71 crore
o Margin at 18.6 percent versus 22.88 percent

Trend in FII flows: The FIIs were Net Value of Rs 461.47   the cash segment on Tuesday while the DIIs were Net Value of Rs -2046.07 as per the provisional figures.

UPCOMING-RESULTS:- ABAN,ARVIND,BHARATFORGE,ASHOKLEY,BALKRISIND,CESC,GSFC,GNFC,IRB,MUTHOOTFIN,MAHANAGAR GAS,NDTV,ORIENTBANK,PETRONET,PIDILITE,SHREECEM,THERMAX,UBL,VOLTAS

Securities in Ban For Trade Date 08-NOV-2017:

1.DHFL
2.HDIL
3.IBREALEST
4.INDIACEM
5.INFIBEAM
6.JSWENERGY
7.RCOM
8.WOCKPHARMA


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.
Also u can visit :-
capitalstars past performance

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

0 comments:

Post a Comment

 
GET A FREE TRIAL